S'abonner

Behavior of general physicians about lung cancer screening in a French region hosting a pilot study - 06/06/23

Doi : 10.1016/j.resmer.2023.100992 
Etienne Marchal a, 1, Claire Burgaud b, 1, Vincent Jounieaux c, Olivier Leleu d,
a Department of Nuclear Medicine, CHU Amiens-Picardie, Amiens, France 
b General practitionner, Amiens, France 
c Department of Pulmonology and Thoracic Oncology, CHU Amiens-Picardie, Amiens, France 
d Department of Pulmonology and Thoracic Oncology, Abbeville Hospital Center, France 

Corresponding author.

Abstract

Introduction

Lung cancer is the leading cause of cancer-related death in France and has a 5-year survival rate of 20%. Recent prospective randomized controlled trials revealed that lung cancer-specific mortality decreased in patients who underwent screening using low-dose chest computed tomography (low-dose CT). The DEP KP80 pilot study conducted in 2016 showed that an organized lung cancer screening campaign involving general practitioners was feasible.

Material and method

We conducted a descriptive observational study of screening practices by sending a self-reported questionnaire to 1013 general practitioners practicing in the Hauts-de-France region.

Our study's primary aim was to investigate the knowledge and practices of general practitioners in the Hauts-de-France region of France regarding lung cancer screening using low-dose CT. The secondary endpoint was to compare practices between general practitioners in the Somme department who had experience of experimental screening and their colleagues in the rest of the region.

Results

The response rate was 18.8% (190 completed questionnaires). Even though 69.5% of the physicians were unaware of the potential benefits of organized low-dose CT screening for lung cancer, 76% proposed screening tests for individual patients. Despite its proven ineffectiveness, chest radiography was still the most widely recommended screening modality. Half of the physicians stated that they had already prescribed chest CT to screen for lung cancer. Additionally, only 36.3% proposed chest CT screening for patients aged over 50 years with a history of more than 30 pack-years. The physicians working in the Somme department (61% had participated in the DEP KP80 pilot study) were more aware of low-dose CT as a screening modality, and offered it significantly more than their colleagues in the other departments (61.1% vs 13.4% p<0.01). All the physicians were in favor of an organized screening program.

Conclusion

More than a third of general practitioners in the Hauts-de-France region offered for lung cancer screening using chest CT, although only 18% specified low-dose CT. Before an organized screening program can be set up, good practice guidelines must be made available about lung cancer screening.

Le texte complet de cet article est disponible en PDF.

Keywords : Screening, Computed tomography, Low dose, Early diagnosis, General practice


Plan


© 2023  SPLF and Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 83

Article 100992- juin 2023 Retour au numéro
Article précédent Article précédent
  • Dysbiosis and leaky gut in hyper-inflated COPD patients: Have smoking and exercise training any role?
  • Laura Comini, Evasio Pasini, Roberto Porta, Adriana Olivares, Cristian Testa, Simonetta Scalvini, Michele Vitacca
| Article suivant Article suivant
  • Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022
  • Antonio Piralla, Francesco Mojoli, Laura Pellegrinelli, Ferruccio Ceriotti, Antonia Valzano, Giacomo Grasselli, Maria Rita Gismondo, Valeria Micheli, Antonio Castelli, Claudio Farina, Marco Arosio, Ferdinando Luca Lorini, Diana Fanti, Andrea Busni, Matteo Laratta, Fabrizio Maggi, Federica Novazzi, Luca Cabrini, Anna Paola Callegaro, Roberto Keim, Giuseppe Remuzzi, Annalisa Cavallero, Sergio Maria Ivano Malandrin, Roberto Rona, Federica Giardina, Guglielmo Ferrari, Federica Zavaglio, Piera D'angelo, Cristina Galli, Laura Bubba, Sandro Binda, Massimo Oggioni, Sara Colonia Uceda Renteria, Patrizia Bono, Andreina Baj, Francesca Drago Ferrante, Davide Guarneri, Marco Tonelli, Gavino Napolitano, Alice Nava, Lorenzo Romeo, Elena Nicolini, Rea Valaperta, Ludovica Varisano, Caterina Mele, Lucia Liguori, Monica Raggi, Silvia Mongodi, Michele Pagani, Paolo Severgnini, Dario Gasberti, Ezio Bonanomi, Paolo Gritti, Francesco Marrazzo, Ilaria Giovannini, Noemi Sacchi, Orlando Sagliocco, Danilo Cereda, Sabrina Buoro, Fausto Baldanti, Elena Pariani

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.